HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mokri, B. Articles by Dyck, P. J. Search for Related Content PubMed PubMed Citation Articles by Mokri, B. Articles by Dyck, P. J.

Disulfiram neuropathy

From the Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, MN.

In four patients, sensorimotor polyneuropathy developed during treatment with disulfiram. Each patient began to improve with the cessation of treatment. Clinical, electrophysiologic, and pathologic observations point to a potentially reversible and probably dose-related axonal polyneuropathy.

Address correspondence and reprint requests to Dr. Mokri, Department of Neurology, Mayo Clinic, Rochester, MN 55905.

This investigation was supported in part by a Peripheral Neuropathy Clinical Center Grant (No. NS14304A) from the National Institutes of Health, Public Health Service; by a Center Grant from MDA 12; and by Mayo, Borchard, Upton, and Gallagher Funds.

Accepted for publication August 18, 1980.

This article has been cited by other articles:

				S. N. Nagendra, M. D. Faiman, K. Davis, J.-Y. Wu, X. Newby, and J. V. Schloss Carbamoylation of Brain Glutamate Receptors by a Disulfiram Metabolite J. Biol. Chem., September 26, 1997; 272(39): 24247 - 24251. [Abstract] [Full Text] [PDF]